These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2460 related articles for article (PubMed ID: 8074484)

  • 1. Evaluation of matrix metalloproteinases and serine proteases activities in three B16 melanoma cell lines with distinct tumorigenic potential.
    Baramova EN; Coucke P; Leprince P; De Pauw-Gillet MC; Bassleer R; Foidart JM
    Anticancer Res; 1994; 14(3A):841-6. PubMed ID: 8074484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metalloproteinases and serine proteases activities in mixed spheroids of mouse b16 melanoma-cells and fibroblasts.
    Coucke P; Baramova E; Leprince P; Depauwgillet M; Foidart J; Bassleer R
    Int J Oncol; 1994 Nov; 5(5):1125-30. PubMed ID: 21559690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and tumorigenicity of spheroids composed of pigmented or non pigmented B16 melanoma cells.
    Coucke PH; De Pauw-Gillet MC; Bonjean KA; Siwek BL; Foidart JM; Bassleer RJ
    In Vivo; 1994; 8(3):333-8. PubMed ID: 7803714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis activity promotes tumor invasiveness of B16 melanoma cell lines through a reconstituted gel matrix.
    Mimura K; Sueishi K; Yasunaga C; Tanaka K
    Invasion Metastasis; 1992; 12(1):24-34. PubMed ID: 1380952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
    Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
    Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells.
    Ueshima S; Fukao H; Okada K; Matsuo O
    Thromb Res; 2004; 113(1):41-9. PubMed ID: 15081564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse trophoblastic cell lines: II--Relationship between invasive potential and proteases.
    Sharma RK
    In Vivo; 1998; 12(2):209-17. PubMed ID: 9627804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate.
    Gross JL; Behrens DL; Mullins DE; Kornblith PL; Dexter DL
    Cancer Res; 1988 Jan; 48(2):291-6. PubMed ID: 3121170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors.
    Colucci M; Gesualdo L; Montemurro P; Cavallo LG; Conese M; Mascolo E; Ranieri E; Di Paolo S; Schena FP; Semeraro N
    Thromb Haemost; 1995 Dec; 74(6):1516-20. PubMed ID: 8772230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.
    de Vries TJ; Quax PH; Denijn M; Verrijp KN; Verheijen JH; Verspaget HW; Weidle UH; Ruiter DJ; van Muijen GN
    Am J Pathol; 1994 Jan; 144(1):70-81. PubMed ID: 8291613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
    Wang BS; McLoughlin GA; Richie JP; Mannick JA
    Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis of human colon tumor cells in vivo: correlation with the overexpression of plasminogen activators and 72 kDa gelatinase.
    Shah V; Kumar S; Zirvi KA
    In Vivo; 1994; 8(3):321-6. PubMed ID: 7803712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
    J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model.
    Pasco S; Ramont L; Venteo L; Pluot M; Maquart FX; Monboisse JC
    Exp Cell Res; 2004 Dec; 301(2):251-65. PubMed ID: 15530861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
    Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
    Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activators in nude mice xenotransplanted with human tumorigenic cells.
    Colombi M; Bellotti D; De Petro G; Barlati S
    Invasion Metastasis; 1995; 15(1-2):22-33. PubMed ID: 7672929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma.
    Häckel C; Czerniak B; Ayala AG; Radig K; Roessner A
    Cancer; 1997 Jan; 79(1):53-8. PubMed ID: 8988726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.
    Bator JM; Cohen RL; Chambers DA
    Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro differentiation of teratomas and the distribution of creatine phosphokinase and plasminogen activator in teratocarcinoma-derived cells.
    Topp W; Hall JD; Marsden M; Teresky AK; Rifkin D; Levine AJ; Pollack R
    Cancer Res; 1976 Nov; 36(11 Pt. 2):4217-23. PubMed ID: 184930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 123.